Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension study. (Q42640551)
Jump to navigation
Jump to search
scientific article published on 16 March 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension study. |
scientific article published on 16 March 2012 |
Statements
Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension study (English)
A Menter
Y Poulin
Y Gu
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference